Contributors to Iron Status: Serum Ferritin, TSAT, and Hemoglobin

All Oral Iron Therapies Are Not Created Equal

Assessing and Addressing ID/IDA: The Need for Guidance  

Pathogenesis of ID and IDA in Reproductive-Aged Women: Focus on Heavy Menstrual Bleeding

Case of the Patient in Midlife: Weighing Potential Changes in ASCCP Guidelines

All Oral Iron Therapies Are Not Created Equal

Assessing and Addressing ID/IDA: The Need for Guidance  

Pathogenesis of ID and IDA in Reproductive-Aged Women: Focus on Heavy Menstrual Bleeding

How a Woman’s Iron Status Today Can Impact a Baby’s Health Tomorrow – and Through the Years 

“In Any Case?” The Importance of Iron Repletion

The Impact and Importance of Iron Status

ID and IDA in Postmenopausal Women 

Strategies to Effectively Manage ID and IDA Throughout the Life Span

Enhancing Adherence with Oral Iron Therapy  

Transforming Cervical Cancer Screening and Management: New Guidelines, New Tests
A Case-Based Discussion

Alloimmune Neutropenia of the Fetus and Newborn

Contributors to Iron Status: Serum Ferritin, TSAT, and Hemoglobin

Why Are the Fetus and Placenta Not Rejected by the Mother? New Insights Into Maternal Anti-Fetal Rejection

Medical Management of Endometriosis: GnRH Antagonists

Mental Health and Menopause: Patient-Centric Approaches

Optimizing Medical Management of Uterine Fibroids: Achieving Patient-Centered Goals and Outcomes

Long-Acting Reversible Contraceptives: Their Critical Role in Addressing Today’s Reproductive Health Landscape

Alloimmune Thrombocytopenia in the Fetus and Newborn